{"transactions":[{"id":905419,"issuer":{"id":6950,"kind":"organization","name":"OS Therapies Inc","symbol":"OSTX"},"owners":[{"id":66522,"kind":"person","name":"Acevedo Christopher P.","position":1,"cik":"0002010225","reported_name":"Acevedo Christopher P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock options (right to buy)","published_at":"2026-02-13T16:42:16.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On January 22, 2026, the reporting person was granted options to purchase 100,000 shares of the issuer's common stock pursuant to the terms and conditions of a stock option award agreement. These options vest in full on the one-year anniversary of the date of grant, provided that the reporting person is serving as an employee of the issuer on such date."}],"balance_after":100000,"derivative":{"exercise_price":1.34,"expiration_date":"2036-01-22","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001213900-26-016501","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2010225/000121390026016501/ownership.xml","form_type":"4"}},{"id":962192,"issuer":{"id":6950,"kind":"organization","name":"OS Therapies Inc","symbol":"OSTX"},"owners":[{"id":66522,"kind":"person","name":"Acevedo Christopher P.","position":1,"cik":"0002010225","reported_name":"Acevedo Christopher P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock options (right to buy)","published_at":"2025-12-19T18:30:19.000Z","date":"2025-10-21","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On October 21, 2025, the reporting person was granted options to purchase 200,000 shares of the issuer's common stock pursuant to the terms and conditions of a stock option award agreement. These options vest in full on the one-year anniversary of the date of grant, provided that the reporting person is serving as an employee of the issuer on such date."}],"balance_after":200000,"derivative":{"exercise_price":1.8,"expiration_date":"2035-10-21","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001213900-25-123993","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2010225/000121390025123993/ownership.xml","form_type":"4"}},{"id":1267728,"issuer":{"id":6950,"kind":"organization","name":"OS Therapies Inc","symbol":"OSTX"},"owners":[{"id":66522,"kind":"person","name":"Acevedo Christopher P.","position":1,"cik":"0002010225","reported_name":"Acevedo Christopher P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Non-qualified stock options (right to buy)","published_at":"2025-02-14T16:21:21.000Z","date":"2024-12-05","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On December 5, 2024, the reporting person was granted non-qualified stock options to purchase 200,000 shares of the issuer's common stock pursuant to the terms and conditions of a stock option award agreement and subject to certain vesting conditions."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On December 5, 2024, the reporting person was granted non-qualified stock options to purchase 200,000 shares of the issuer's common stock pursuant to the terms and conditions of a stock option award agreement and subject to certain vesting conditions."}],"balance_after":200000,"derivative":{"exercise_price":1.86,"underlying":"Common stock, par value $0.001 per share","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000921895-25-000490","document":"form513679001ace_02142025.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2010225/000092189525000490/form513679001ace_02142025.xml","form_type":"5"}}]}